Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Liposarcoma × Dactinomycin × Clear all

Sponsor

Conditions

Rhabdomyosarcoma 5 Sarcoma 4 Wilms Tumor 2 Hydatidiform Mole 2 Rhabdomyosarcoma, Embryonal 1 Rhabdomyosarcoma, Alveolar 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Melanoma 1 Malignant mesenchymal tumor 1 Lymphoma 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia 1 Fibrosarcoma 1 Choroid Plexus Neoplasms 1 Choriocarcinoma 1 Carcinoma, Renal Cell 1 Brain Neoplasms 1 Blast Crisis 1 Beckwith-Wiedemann Syndrome 1

Interventions

Doxorubicin 6 pazopanib 4 Trabectedin 4 Radiotherapy 3 temsirolimus 2 eribulin 2 Sunitinib 2 Radiotherapy, Conformal 2 Ifosfamide 2 Dexamethasone 2 sitravatinib 1 selinexor 1 saracatinib 1 romidepsin 1 regorafenib 1 plitidepsin 1 pembrolizumab 1 palbociclib 1 olaratumab 1 milademetan 1 liposomal doxorubicin 1 lenvatinib 1 indolepropanol phosphate 1 efatutazone 1 cixutumumab 1 brigimadlin 1 avelumab 1 atezolizumab 1 Watchful Waiting 1 Topotecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡